INTRODUCTION
Ambroxol is an active N-desmethyl metabolite of the mucolytic bromohexine. It is indicated for acute and chronic
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Biodegradable Chitosan-Based Ambroxol Hydrochloride
Microspheres: Effect of Cross-Linking Agents of the polysaccharide, Chitin. It has been used by a number of authors as a matrix-forming material in microspheres because of its biodegradable nature, nontoxicity, biocompatibility, and mucoadhesivity. [8] [9] [10] [11] These multiparticulate solid dosage forms have a number of advantages such as more uniform distribution of the drug in the GIT, more uniform drug absorption, reduced local irritation, and elimination of unwanted intestinal retention of polymeric material. Different methods such as ionotropic gelation, [8, 12] spray drying, [13, 14] emulsificationsolvent evaporation [15, 16] are mentioned in the literature for preparation of chitosan microspheres.
In this study, we prepared chitosan microspheres using solvent evaporation techniques and evaluated the effect of methods of cross-linking such as cross-linking by chemical such as formaldehyde [17] and cross-linking by heat treatment [18] onto the encapsulation efficiency, particle size, and drug release. The cross-linked microspheres from the optimized formulations were then characterized by FTIR, DSC, XRD, and SEM.
MATERIALS AND METHODS
Materials
Ambroxol hydrochloride was obtained as a gift sample from Glenmark Pharmaceutical Ltd., Nasik and chitosan from Central Fisheries Research Institute, Kochi, India. Acetic acid and formaldehyde (35% w/v) solutions were purchased from S.D. Fine Chemicals, Mumbai, India. All other chemicals used were of analytical grade.
Methods
Preparation of chitosan microspheres
Initially, chitosan (100 mg) was dissolved in 2 %v/v acetic acid solution. The drug (100 mg) was then added to it, and the suspension was extruded through syringe in 200 mL of 1:1 mixture of heavy and light liquid paraffin containing 1 %w/v SPAN80. The resulting emulsion was then stirred using propeller stirrer (Remi's Equipment, Mumbai) at 500 rpm. After 30 min, the developed microspheres were cross-linked chemically (formaldehyde-FA) or by the heat treatment (H), as explained follows: (a) To produce the FA-crosslinked chitosan microspheres, 1 mL of formaldehyde was added to emulsion and stirring was continued for 6 h. Cross-linked microspheres thus formed were separated by filtration, washed repeatedly with hexane, followed by water to remove the paraffin, acid, and the excess of the cross-linking agent.
Microspheres were prepared with varying ratios of 
Drug entrapment efficiency
Weighed quantity of microspheres were crushed and suspended in distilled water for 24 h to extract the drug from microspheres. The filtrate was then analyzed at 244.4 nm using UV-Vis spectrophotometer (JASCO V630, Japan) for drug content. The encapsulation efficiency was calculated using following equation: Encapsulation efficiency = (Drug entrapped/Theoretical drug content) × 100.
Particle size analysis of microspheres Average particle diameter and size distribution of microspheres were determined by laser diffractometry using a Mastersizer Micro V 2.19 (Malvern Instruments, Malvern, UK). Approximately, 10 mg of microspheres were dispersed in 10 mL distilled water containing 0.1 %v/v Tween 80 for 1 min using an ultrasonic bath. Then, an aliquot of the microspheres suspension was added into recirculation unit, which was subsequently circulated 3500 times/min. Particle size was expressed as equivalent volume diameter. The analysis was carried out in triplicate. The particle size distribution was also expressed in terms of SPAN factor determined as:
where d 10 , d 50 , and d 90 are the diameter sizes, and the given percentage value is the percentage of particles smaller than that size. A high SPAN value indicates a wide size distribution. [14] Scanning electron micrography The microspheres were scanned using scanning electron
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microscope (Leica-Stereoscan-440). For the SEM, the microspheres were mounted directly on to the SEM sample slab using double-sided sticking tape and coated with gold film thickness of 200 mm under reduced pressure of 0.001 mmHg. The shape and surface characteristic of the microspheres was observed under electron microanalyzer and photographs were taken using SM 4504 camera.
X-ray diffractometry
X-ray powder diffractometry was carried out to investigate the effect of microencapsulation process on crystallinility of drug. Powder XRD pattern was recorded on XRD (Philips-PW-1050) with filter Ni, Cu Kα radiation, voltage 40 kV, and a current of 20 mA. The scanning rate employed was 1°C/min over the 5° to 50° diffraction angle (2θ) range. The XRD patterns of drug powder, polymer, and drug-loaded microspheres were recorded.
Differential scanning calorimetry
The DSC analysis of pure drug, polymer, and drug-loaded microspheres was carried using DSC (Mettler TC 11, TA Processor). The samples (6 mg each) were placed into a pierced aluminum sample container. The studies were carried out under a static air atmosphere in the temperature range of 50-500°C, at a heating rate of 10°C/min. The peak temperatures were determined after calibration with standard.
Fourier-transform infrared spectroscopy
Drug-polymer interactions were studied by FTIR spectroscopy. The spectra were recorded for pure drug, polymer, and drug-loaded microspheres using FTIR spectrophotometer (Jasco FTIR-410). Samples were prepared by KBr disk method and the scanned over the range of 400-4000 cm -1 , and the resolution was 2/cm.
In vitro drug release studies
Microspheres equivalent to 75 mg ambroxol hydrochloride were filled in a capsule [13] and in vitro drug release was studied using USP Apparatus I with 900 mL of dissolution medium at 37.5 ± 0.1°C for 12 h at 100 rpm. Then, 0.1 N HCl (pH 1.2) was used as dissolution medium for the first 2 h, followed by pH 6.8 phosphate buffer for further 10 h. Five milliliters mL of sample was withdrawn after every hour and was replaced with an equal volume of fresh dissolution medium. Collected samples were analyzed at 244.4 nm spectrophotometrically. The study was performed in triplicate. Dissolution study was also conducted for marketed capsule Mucolite ® SR (M1).
Release kinetics
Data obtained from in vitro release studies were fitted to various kinetics equations to find out the mechanism of drug release from microspheres. The kinetics models used were zero order, first order, and Higuchi models. The rate constants were also calculated for the respective models.
RESULTS AND DISCUSSION
This study was undertaken to evaluate the effect of the method of cross-linking onto the performance of chitosan microspheres. Chitosan was cross-linked chemically using formaldehyde or thermally by heat treatment. Ambroxol hydrochloride was chosen as the model drug.
Morphology and drug encapsulation efficiency
Thermally cross-linked (H3) microspheres were found to be spherical, discrete, and smooth surfaced with distinct pores as compared to the microspheres cross-linked using formaldehyde [ Figure 1 ]. Drug encapsulation efficiency was found to be 39.73-58.65% for thermally cross-linked microspheres whereas it was 68.45-80.56% for chemically cross-linked ones [ Table 1 ]. The high-drug encapsulation for formaldehyde cross-linked microspheres could be because of formation of more strong and rigid matrix as it involves actual chemical reaction between formaldehyde and chitosan.
Effect on particle size
Particle size for ther mally cross-linked chitosan microspheres was found to be 18.00-24.11 µm and for chitosan microspheres cross-linked by formaldehyde was found to be 10.83-17.91 µm. It was seen that the particle size of microspheres increased as the concentration of polymer increased, and this may be because of the fact that increase in polymer concentration causes increase in the viscosity of inner phase, which leads to increased crosslinking. This increased matrix density of polymer may result in the increase in the particle size of the microspheres. As cross-linking by formaldehyde was more rigid and strong, particle size of such microspheres was small as compared to thermally cross-linked microspheres. SPAN factor ranged in between 1.77 and 2.289, indicating narrow size of distribution.
In vitro drug release
In vitro dissolution study revealed that microspheres showed sustained drug release beyond 8 h. It was clear from Figure 2 that drug-release rate decreased as the chitosan concentration increased. The drug release from the developed microspheres was biphasic showing initial burst effect (rapid drug release) followed by slow diffusion of drug. It was also seen that drug release from these biodegradable microspheres was also dependent upon the type and rigidity of matrix. It was already stated that cross-linking by formaldehyde forms more rigid and strong matrix due to covalent imine bond formation between aldehyde group of formaldehyde and the amino groups of chitosan. [12] Therefore, the drug release through FA crosslinked microspheres was slow as compared to thermally cross-linked microspheres.
In vitro dissolution results showed that the H3 and FA3 microspheres maintained better-sustained action up to a period of 12 h. However, cross-linking by chemical agent like formaldehyde is harmful because the traces of this toxic chemical in the chitosan microspheres can cause irritation to mucosal membranes and also it is difficult to ensure that the chitosan microspheres are absolutely free from the cross-linking agent. Hence, H3 microspheres were considered as optimized formulation and it was used further evaluated for compatibility study between drug and the polymer and surface characterization.
Kinetic treatment of dissolution data
All the formulations followed Higuchi's kinetics with R 2 ranging from 0.991 to 0.999 [ Table 2 ]. The mechanism of drug release was analyzed by Korsmeyer-Peppas equation using n value. The value of n varies between 0.22 and 0.35, Similarity factor (f 2 ) and difference factor (f 1 ) were calculated for optimized microspheres considering marketed capsule as the reference standard. It was found that f 1 and f 2 value for H3 were 51.83 and 3.06, respectively. This suggested that H3 microspheres showed similarities of dissolution profiles with that of marketed capsule [ Figure 3 ]. T 90% of H3 and marketed capsule was 10.3 and 9.48 h, respectively, which suggested that these microspheres showed release profiles comparable with that of marketed capsule.
X-ray diffractometry
Characteristic crystalline peaks of ambroxol hydrochloride was absent in the XRD of ambroxol hydrochloride-loaded chitosan microspheres which suggested that drug might be in amorphous nature in microspheres [ Figure 4 ].
Differential scanning calorimetry
Endothermic peak of pure ambroxol hydrochloride at 243°C was absent in ambroxol-loaded chitosan microsphere, which suggested that drug might have shown molecular dispersity in microspheres [ Figure 5 ].
Fourier transform infra-red spectroscopy
Characteristic peak of chitosan polymer were located at 3430 cm -1 for OH group, 1654 cm -1 for carbonyl stretching vibration, and at 1616 cm -1 for amino group. In case of drug-loaded chitosan microspheres peak at 1719 cm -1 might be due imine bond formed in cross-linked chitosan [ Figure 6 ]. However, the peaks of drug not obtained exactly in drug-loaded microspheres, which suggested that nature of drug might be changed to amorphous.
CONCLUSION
This study was designed to evaluate the effect of the method of cross-linking onto the performance of chitosan microspheres and from the outcome of the investigation it can be concluded that though formaldehyde gives better cross-linking effect for chitosan microspheres, however, due to its toxic nature and inability to remove its traces from the microspheres, one has to think about the alternative method for cross-linking and heat treatment is found to be better alternative as it could control the drug release to the desired extent and resulted in excellent microspheres with narrow size distribution.
